Testing effectiveness (Phase 2)Study completedNCT02314364
What this trial is testing
A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC
Who this might be right for
Non-small Cell Lung Cancer MetastaticTargetable Oncogenes (EGFR, ALK, ROS1)
Massachusetts General Hospital 27